Search Results - "Agazie, Y M"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells by Zhou, X-D, Agazie, Y M

    Published in Cell death and differentiation (01-06-2008)
    “…The Src homology phosphotyrosyl phosphatase 2 (SHP2) is an essential transducer of mitogenic and cell survival signaling in the epidermal growth factor…”
    Get full text
    Journal Article
  2. 2

    SHP2 is up-regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesis by Zhou, X, Coad, J, Ducatman, B, Agazie, Y M

    Published in Histopathology (01-10-2008)
    “…Aims:  To determine whether Src homology phosphotyrosyl phosphatase 2 (SHP2) is up‐regulated in breast cancer and, if so, to determine whether its…”
    Get full text
    Journal Article
  3. 3

    Modulation of α-catenin Tyr phosphorylation by SHP2 positively effects cell transformation induced by the constitutively active FGFR3 by BURKS, J, AGAZIE, Y. M

    Published in Oncogene (16-11-2006)
    “…The Src homology 2 phosphotyrosyl phosphatase (SHP2) is a nonreceptor-type phosphatase that acts as a positive transducer of receptor Tyr kinase (RTK)…”
    Get full text
    Journal Article
  4. 4

    HER2 stabilizes EGFR and itself by altering autophosphorylation patterns in a manner that overcomes regulatory mechanisms and promotes proliferative and transformation signaling by Hartman, Z, Zhao, H, Agazie, Y M

    Published in Oncogene (29-08-2013)
    “…One of the causes of breast cancer is overexpression of the human epidermal growth factor receptor 2 (HER2). Enhanced receptor autophosphorylation and…”
    Get full text
    Journal Article
  5. 5

    Regulation of anti-apoptotic signaling by Kruppel-like factors 4 and 5 mediates lapatinib resistance in breast cancer by Farrugia, M K, Sharma, S B, Lin, C-C, McLaughlin, S L, Vanderbilt, D B, Ammer, A G, Salkeni, M A, Stoilov, P, Agazie, Y M, Creighton, C J, Ruppert, J M

    Published in Cell death & disease (01-03-2015)
    “…The Kruppel-like transcription factors (KLFs) 4 and 5 (KLF4/5) are coexpressed in mouse embryonic stem cells, where they function redundantly to maintain…”
    Get full text
    Journal Article
  6. 6

    Development of an Efficient “Substrate-trapping” Mutant of Src Homology Phosphotyrosine Phosphatase 2 and Identification of the Epidermal Growth Factor Receptor, Gab1, and Three Other Proteins as Target Substrates by Agazie, Yehenew M., Hayman, Michael J.

    Published in The Journal of biological chemistry (18-04-2003)
    “…Src homology containing phosphotyrosine phosphatase 2 (SHP2) is a positive effector of growth factor, cytokine, and integrin signaling. However, neither its…”
    Get full text
    Journal Article
  7. 7

    The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3 by AGAZIE, Yehenew M, MOVILLA, Nieves, ISCHENKO, Irene, HAYMAN, Michael J

    Published in Oncogene (09-10-2003)
    “…Receptor tyrosine kinases (RTKs) such as the fibroblast growth factor receptor (FGFR) and the epidermal growth factor receptor are overexpressed in a variety…”
    Get full text
    Journal Article
  8. 8

    ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways by Wilden, P A, Agazie, Y M, Kaufman, R, Halenda, S P

    Published in The American journal of physiology (01-10-1998)
    “…Vascular smooth muscle cells respond to the purinergic agonist ATP by increasing intracellular calcium concentration and increasing the rate of cell…”
    Get full text
    Journal Article
  9. 9

    Triplex DNA in the nucleus: direct binding of triplex-specific antibodies and their effect on transcription, replication and cell growth by Agazie, Y M, Burkholder, G D, Lee, J S

    Published in Biochemical journal (01-06-1996)
    “…Jel 318 and Jel 466 are triplex-specific monoclonal antibodies which previously have been shown to bind to cell nuclei and chromosomes by immunofluorescence…”
    Get full text
    Journal Article
  10. 10

    Characterization of a new monoclonal antibody to triplex DNA and immunofluorescent staining of mammalian chromosomes by MEKONNEN AGAZIE, Y, LEE, J. S, BURKHOLDER, G. D

    Published in The Journal of biological chemistry (04-03-1994)
    “…A monoclonal antibody, Jel 466, was prepared from mice immunized with poly[d(Tm5C)].poly[d(GA)]. The binding of Jel 466 to nucleic acids was characterized by…”
    Get full text
    Journal Article
  11. 11

    Molecular mechanisms of ATP and insulin synergistic stimulation of coronary artery smooth muscle growth by Agazie, Y M, Bagot, J C, Trickey, E, Halenda, S P, Wilden, P A

    “…Coronary artery disease (CAD) is the major cause of death in diabetics. Abnormal proliferation of coronary artery smooth muscle cells (CASMC) leads to intimal…”
    Get more information
    Journal Article
  12. 12

    Modulation of -catenin Tyr phosphorylation by SHP2 positively effects cell transformation induced by the constitutively active FGFR3 by Burks, J, Agazie, Y M

    Published in Oncogene (16-11-2006)
    “…The Src homology 2 phosphotyrosyl phosphatase (SHP2) is a nonreceptor-type phosphatase that acts as a positive transducer of receptor Tyr kinase (RTK)…”
    Get full text
    Journal Article
  13. 13

    Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling by Agazie, Yehenew M., Hayman, Michael J.

    Published in Molecular and Cellular Biology (01-11-2003)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14

    P3-01-15: The Role of Src Homology Phosphotyrosyl Phosphatase-2 in Basal-Type/Triple-Negative Breast Cancer – Implications for Targeted Therapy by Agazie, YM, Matalka, F, Hartman, ZR

    Published in Cancer research (Chicago, Ill.) (15-12-2011)
    “…Abstract Background: Of all breast cancer subtypes, the basal-type/triple-negative breast cancer (BTBC) has the worst clinical outcome. The major reasons are…”
    Get full text
    Journal Article
  15. 15

    P2-02-05: Molecular Mechanism for Src Homology Phosphotyrosyl Phosphatase 2 Regulation of Cell Motility and Migration by Hartman, ZR, Agazie, YM

    Published in Cancer research (Chicago, Ill.) (15-12-2011)
    “…Abstract Background: The Src homology phosphotyrosyl phosphatase 2 (SHP2) acts as a transducer of mitogenic and cell survival signaling downstream of receptor…”
    Get full text
    Journal Article
  16. 16

    Specificity of monoclonal antibodies produced against phosphorothioate and ribo modified DNAs by Latimer, Laura J.P., Agazie, Yehenew M., Braun, Ralph P., Hampel, Ken J., Lee, Jeremy S.

    Published in Molecular immunology (01-10-1995)
    “…A large number of phosphorothioate DNAs and mixed ribo/deoxyribo duplexes were prepared and their immunogenicity was studied in mice. Only those polymers which…”
    Get full text
    Journal Article
  17. 17

    Mutation of Thr466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutant by Merritt, Rebecca, Hayman, Michael J., Agazie, Yehenew M.

    Published in Biochimica et biophysica acta (2006)
    “…Most classical phosphotyrosyl phosphatases (PTPs), including the Src homology phosphotyrosyl phosphatase 2 (SHP2) possess a Thr or a Ser residue immediately…”
    Get full text
    Journal Article